| Investment Austasia Limited (IAL) ORDINARY FULLY PAID |
Industrials |
- |
mFund - Fund Profile - IAL02
|
20 Nov 2025 10:12AM |
n/a |
n/a |
n/a
|
|
| Archer Materials Limited (AXE) ORDINARY FULLY PAID |
Information Technology |
$90 |
Chair's 2025 AGM address
|
20 Nov 2025 10:12AM |
$0.370 |
$0.355 |
fallen by
4.05%
|
|
| Ausmon Resources Limited (AOA) ORDINARY FULLY PAID |
Materials |
$3 |
Rare earth elements laboratory results from samples in SA
|
20 Nov 2025 10:12AM |
$0.003 |
$0.002 |
fallen by
33.33%
|
|
AOA - Price-sensitive ASX Announcement
Full Release
Key Points
- Laboratory assay results received for rare earth elements at Jabuk Prospect.
- September 2025 Aircore Drilling program covered 418 meters with 23 drill holes.
- 24 samples showed elevated REE readings between 130 ppm to 753 ppm.
- Further exploration planned with grid-based vertical aircore drilling over 10 km2.
- Community consultations and access agreements are required for land exploration.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ReadCloud Limited (RCL) ORDINARY FULLY PAID |
Information Technology |
$12 |
FY25 Full Year Results Release
|
20 Nov 2025 10:07AM |
$0.110 |
$0.081 |
fallen by
26.36%
|
|
RCL - Price-sensitive ASX Announcement
Full Release
Key Points
- 109% increase in Underlying EBITDA
- 26% organic growth in VET-in-Schools revenue to $5.7 million
- 17% growth in direct eBook sales to Australian Schools
- Total revenue of $12.9 million, up 5%
- Positive cash flow with $1.9 million cash at 30 September
- Strategic focus on school-facing operations for sustained growth
- Southern Solutions under review due to revenue headwinds
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Shriro Holdings Limited (SHM) ORDINARY FULLY PAID |
Consumer Discretionary |
$56 |
Becoming a substantial holder
|
20 Nov 2025 10:07AM |
$0.790 |
$0.780 |
fallen by
1.27%
|
|
| HitIQ Limited (HIQ) ORDINARY FULLY PAID |
Health Care |
$11 |
HITIQ Launches PROTEQT North American Market Strategy
|
20 Nov 2025 10:07AM |
$0.020 |
$0.018 |
fallen by
10%
|
|
HIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- PROTEQTâ„¢ North American Launch with a dual-channel approach.
- Rick Shultz appointed as the exclusive Canadian distributor.
- Canada has over 600,000 registered hockey players.
- Immediate commercial momentum with founding order.
- Pilot program deployed at elite-level hockey.
- Production capacity planned for 100,000 units in 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| LTR Pharma Ltd (LTP) ORDINARY FULLY PAID |
Health Care |
$84 |
Notification regarding unquoted securities - LTP
|
20 Nov 2025 10:06AM |
$0.450 |
$0.460 |
risen by
2.22%
|
|
| MaxiPARTS Limited (MXI) ORDINARY FULLY PAID |
Industrials |
$106 |
Chair's Address to Shareholders
|
20 Nov 2025 10:02AM |
$2.400 |
$1.915 |
fallen by
20.21%
|
|
| ReadCloud Limited (RCL) ORDINARY FULLY PAID |
Information Technology |
$12 |
FY25 Full Year Results Presentation
|
20 Nov 2025 10:02AM |
$0.110 |
$0.081 |
fallen by
26.36%
|
|
RCL - Price-sensitive ASX Announcement
Full Release
Key Points
- Sales and fee revenue up 6% driven by VET-in-Schools and direct eBook sales.
- VET-in-Schools revenue grew by 26% with high customer retention.
- Australian direct eBooks sales increased by 17%.
- Industry training revenue declined by 28%.
- Consolidated gross profit increased by 11%.
- Operating expenses increased by 4%, maintaining cost discipline.
- Underlying EBITDA grew by 109% year-on-year.
- Strategic focus on customer retention and onboarding new schools.
- FY26 priorities include extending earnings momentum and increasing customer value.
- The company maintains a strong cash position and is debt-free.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cyprium Metals Limited (CYM) ORDINARY FULLY PAID |
Materials |
$245 |
Cathode Restart Approved by Cyprium Board
|
20 Nov 2025 10:01AM |
$0.330 |
$0.425 |
risen by
28.79%
|
|
CYM - Price-sensitive ASX Announcement
Full Release
Key Points
- Cathode Restart Approved by Cyprium Board
- Re-leaching of existing heap leach pads
- Refurbishment of SXEW plant
- Expected first cathode production in mid-2026
- Strategic transition from developer to copper producer
- Potential for future growth from open pit and regional ore sources
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WAM Global Limited (WGB) ORDINARY FULLY PAID |
Financials |
$814 |
Gabrielle Trainor Appendix 3Y
|
20 Nov 2025 10:01AM |
$2.400 |
$2.270 |
fallen by
5.42%
|
|
| Acorn Capital Investment Fund Limited (ACQ) ORDINARY FULLY PAID |
Financials |
$87 |
Annual General Meeting Presentation
|
20 Nov 2025 10:01AM |
$0.885 |
$0.970 |
risen by
9.60%
|
|
ACQ - Price-sensitive ASX Announcement
Full Release
Key Points
- ACQ declared dividends of 5.5 cents per share for FY25.
- The fund achieved a gross portfolio return of 12.6% per annum since inception.
- ACQ's investment strategy focuses on diversification and strong microcap sector performance.
- The portfolio includes exposure to both listed and unlisted microcap companies.
- ACQ is well-positioned to take advantage of improving conditions in the microcap sector.
- Resolutions included adoption of annual and remuneration reports and re-election of directors.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BETR Entertainment Limited (BBT) ORDINARY FULLY PAID |
Consumer Discretionary |
$245 |
Change of Director's Interest Notice - M Tripp
|
20 Nov 2025 9:59AM |
$0.230 |
$0.235 |
risen by
2.17%
|
|
| LTR Pharma Ltd (LTP) ORDINARY FULLY PAID |
Health Care |
$84 |
Application for quotation of securities - LTP
|
20 Nov 2025 9:59AM |
$0.450 |
$0.460 |
risen by
2.22%
|
|
| ReadCloud Limited (RCL) ORDINARY FULLY PAID |
Information Technology |
$12 |
Appendix 4E and Annual Report
|
20 Nov 2025 9:59AM |
$0.110 |
$0.081 |
fallen by
26.36%
|
|
RCL - Price-sensitive ASX Announcement
Full Release
Key Points
- Total revenue of $12.92 million for the year ended 30 September 2025.
- Net loss after tax reduced to $415,898 from the previous year's $1.02 million.
- Major revenue sources include eBook solutions and vocational education and training.
- Significant expenditures include employment costs and publisher fees.
- Total assets valued at $11.58 million, with liabilities at $2.5 million.
- Net assets are approximately $9.08 million.
- Emphasis on strategic initiatives for enhancing shareholder value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WAM Global Limited (WGB) ORDINARY FULLY PAID |
Financials |
$814 |
Kate Thorley Appendix 3Y
|
20 Nov 2025 9:59AM |
$2.380 |
$2.270 |
fallen by
4.62%
|
|
| Amplia Therapeutics Limited (ATX) ORDINARY FULLY PAID |
Health Care |
$59 |
Positive Response from US FDA to Amplia's Type D Meeting
|
20 Nov 2025 9:59AM |
$0.115 |
$0.115 |
fallen by
0%
|
|
ATX - Price-sensitive ASX Announcement
Full Release
Key Points
- Amplia Therapeutics Limited received a positive response from the US FDA during a Type D meeting for their planned Phase 2b/3 trial involving narmafotinib, gemcitabine, and Abraxane for pancreatic cancer.
- The FDA supports the two-dose comparison in the Phase 2b study leading into the pivotal Phase 3 stage.
- The proposed changes will minimally impact the planned timelines for the trial.
- The full trial protocol is set to be prepared for FDA review in the first half of 2026, with the study expected to start in late 2026.
- A Type D meeting is a formal FDA interaction allowing companies to obtain specific regulatory feedback outside the standard review cycle.
- Amplia's primary compound, narmafotinib (AMP945), is a FAK inhibitor used in treating pancreatic cancer.
- The ACCENT trial has shown promising results with narmafotinib, achieving a confirmed response rate of 33%.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| IPH Limited (IPH) ORDINARY FULLY PAID |
Industrials |
$873 |
2025 AGM Addresses and FY26 Trading Update
|
20 Nov 2025 9:59AM |
$3.510 |
$3.340 |
fallen by
4.84%
|
|
IPH - Price-sensitive ASX Announcement
Full Release
Key Points
- Statutory Net Profit After Tax increased to $68.8 million in FY25.
- Underlying EBITDA rose by 6.0% to $207.2 million due to Canadian acquisitions.
- IPH reported a decline in US PCT filings affecting Australia and NZ.
- Challenges in Canada due to CIPO system disruptions are beginning to resolve.
- Strategic focus on empowering member firms and leveraging AI.
- Continued commitment to sustainability and operational excellence.
- Unaudited group revenue for the first four months of FY26 was $241.7 million.
- Group Underlying EBITDA for the same period was $72.4 million.
- Ongoing decline of US PCT filings led to a refocus on other markets.
- CEO Andrew Blattman to retire in the second half of 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Schroder Global Equity Alpha Fund - Active ETF (ALPH) |
Financials |
$8 |
ALPH - Monthly Factsheet
|
20 Nov 2025 9:58AM |
$11.210 |
$10.400 |
fallen by
7.23%
|
|
| Dalrymple Bay Infrastructure Limited (DBI) FULLY PAID ORDINARY/NOTES STAPLED SECURITIES |
Industrials |
$2,360 |
Investor Presentation - Dalrymple Bay Terminal Site Visit
|
20 Nov 2025 9:57AM |
$4.280 |
$4.760 |
risen by
11.21%
|
|
| QuickFee Limited (QFE) ORDINARY FULLY PAID |
Financials |
$29 |
Change of Directors Interest Notice - Bruce Coombes
|
20 Nov 2025 9:57AM |
$0.130 |
$0.075 |
fallen by
42.31%
|
|
| Star Minerals Limited (SMS) ORDINARY FULLY PAID |
Materials |
$14 |
Star Minerals - South-West Connect Presentation
|
20 Nov 2025 9:57AM |
$0.044 |
$0.064 |
risen by
45.45%
|
|
| FleetPartners Group Limited (FPR) ORDINARY FULLY PAID |
Financials |
$537 |
Change of Director's Interest Notice
|
20 Nov 2025 9:57AM |
$2.860 |
$2.485 |
fallen by
13.11%
|
|
| Servcorp Limited (SRV) ORDINARY FULLY PAID |
Real Estate |
$664 |
Application for quotation of securities - SRV
|
20 Nov 2025 9:56AM |
$7.060 |
$6.650 |
fallen by
5.81%
|
|
| ReadCloud Limited (RCL) ORDINARY FULLY PAID |
Information Technology |
$12 |
Appendix 4G and Corporate Governance Statement
|
20 Nov 2025 9:56AM |
$0.110 |
$0.081 |
fallen by
26.36%
|
|